Toggle light / dark theme

Dr. Ana Diaz Artiles: “When we’re upright, a large part of our fluids are stored in our legs, but in microgravity we get a redistribution of fluids into the upper body.”


What physiological effects can extended periods of microgravity have on the human eye? This is what a recent study published in npj Microgravity hopes to address as a team of researchers investigated how the shifting of fluids under microgravity conditions could lead to eye vessel alterations. This study holds the potential to help space agencies, researchers, and the public better understand the short-and long-term physiological effects of microgravity, specifically with more humans traveling beyond Earth’s gravity on commercial spaceflights.

“When we experience microgravity conditions, we see changes in the cardiovascular system because gravity is not pulling down all these fluids as it typically does on Earth when we are in an upright position,” said Dr. Ana Diaz Artiles, who is an assistant professor in the Department of Aerospace Engineering at Texas A&M University and a co-author on the study. “When we’re upright, a large part of our fluids are stored in our legs, but in microgravity we get a redistribution of fluids into the upper body.”

For the study, the researchers analyzed how lower body negative pressure (LBNP), which involves the transferring of fluids from the upper body to the lower body, could potentially be used to counteract what’s known as Spaceflight Associated Neuro-ocular Syndrome (SANS), which, while still not well understood, often results in physiological changes in the eyes, also called ocular prefusion pressure (OPP). Using 24 participants, 12 male and 12 female, the researchers subjected the participants to treatments inside an LBNP chamber to ascertain the effects on counteracting OPP.

Researchers at the National Institutes of Health (NIH) have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.

In a clinical trial at NIH’s National Cancer Institute (NCI), researchers tested the combination of venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (called ViPOR) in 50 patients with DLBCL, the most common type of lymphoma. The treatment shrank tumors substantially in 26 of 48 (54%) evaluable patients, with 18 (38%) of those patients’ tumors disappearing entirely, known as a complete response. At two years, 36% of all patients were alive and 34% were free of disease. These benefits were seen mainly in people with two specific subtypes of DLBCL.

The findings were published June 20, 2024, in the New England Journal of Medicine.

The model is already available for free on http://claude.ai and the Claude iOS app.

Claude 3.5 Sonnet is their our strongest vision model.

Sonnet…


Talk with Claude, an AI assistant from Anthropic.

Is our brain responsible for how we react to people who are different from us? Why can’t people with autism tell lies? How does the brain produce empathy? Why is imitation a fundamental trait of any social interaction? What are the secret advantages of teamwork? How does the social environment influence the brain? Why is laughter different from any other emotion?

This course is aimed at deepening our understanding of how the brain shapes and is shaped by social behavior, exploring a variety of topics such as the neural mechanisms behind social interactions, social cognition, theory of mind, empathy, imitation, mirror neurons, interacting minds, and the science of laughter.

Serious Science experts from leading universities worldwide answer these and other questions. This course offers a range of scientific perspectives on classical philosophical problems in ethics. It is comprised of 10 lectures filmed from 2014 to 2020. If you have any questions or comments on the content of this course, please write to us at [email protected].

HomePage

Learn more about quantum computing on Brilliant! First 30 days are free and 20% off the annual premium subscription when you use our link ➜ https://brilliant.org/sabine.

Quantum computing, so the fairy tale goes, is the next big thing in technology. News has popped up time and time again noting major advancements in the field, but the latest statement from company D-Wave had people scratching their heads. Are quantum computers really the next big thing? Who’s at the forefront of the field now? Let’s have a look.

Paper: https://arxiv.org/abs/2406.01743v1

🤓 Check out my new quiz app ➜ http://quizwithit.com/

An article from last year that’s still relevant.

2023 article

Researchers investigated when the body starts exerting more energy to keep itself cool at high temperatures.

They found that this upper-temperature limit lies between 40℃ (104F) and 50℃ (122F) when the human body stops functioning…